Related Experiment Videos
Animal carcinogenicity studies: implications for the REACH system.
Andrew Knight1, Jarrod Bailey, Jonathan Balcombe
1Animal Consultants International, 91 Vanbrugh Court, Wincott Street, London SE11 4NR, UK. info@animalconsultants.org
Alternatives to Laboratory Animals : ATLA
|March 25, 2006
Summary
Animal testing for chemical carcinogens is unreliable for human health risk assessment. Replacing animal bioassays with non-animal tests offers better prediction of cancer risk and conserves resources.
Area of Science:
- Toxicology
- Chemical Safety Assessment
- Regulatory Science
Background:
- The Registration, Evaluation and Authorisation of Chemicals (REACH) aims to protect health by assessing chemical toxicity.
- Accurate identification of chemical carcinogens is crucial for REACH, with cancer incidence reduction as a key expected benefit.
- Current reliance on animal testing for carcinogen identification faces limitations due to data variability and extrapolation challenges.
Purpose of the Study:
- To evaluate the adequacy of animal carcinogenicity data for classifying chemical risks to humans.
- To propose alternative methods for more accurate human carcinogenicity prediction within regulatory frameworks like REACH.
- To highlight the limitations of animal models in predicting human carcinogenic potential.
Main Methods:
- Surveyed the US Environmental Protection Agency's (EPA) toxic chemicals database for carcinogenicity data adequacy.
- Analyzed the variety of species, administration routes, and affected organ systems in animal carcinogenicity studies.
- Compared EPA assessments with International Agency for Research on Cancer (IARC) evaluations for identical chemicals.
Main Results:
- Animal carcinogenicity data was inadequate for classifying 58.1% (93/160) of chemicals of high public health concern.
- Significant biological variability in animal models complicates accurate extrapolation of findings to humans.
- Discrepancies in IARC assessments of identical chemicals suggest poor predictive accuracy of animal data.
Conclusions:
- Animal carcinogenicity bioassays are insufficient for reliable human risk assessment.
- A tiered approach using non-animal assays can provide superior human predictivity for carcinogenic risk.
- Alternative methods offer resource savings and enhanced understanding of carcinogenicity mechanisms.